Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein.

Luthi AJ, Lyssenko NN, Quach D, McMahon KM, Millar JS, Vickers KC, Rader DJ, Phillips MC, Mirkin CA, Thaxton CS.

J Lipid Res. 2015 May;56(5):972-85. doi: 10.1194/jlr.M054635. Epub 2015 Feb 4.

2.

Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.

Jensen SA, Day ES, Ko CH, Hurley LA, Luciano JP, Kouri FM, Merkel TJ, Luthi AJ, Patel PC, Cutler JI, Daniel WL, Scott AW, Rotz MW, Meade TJ, Giljohann DA, Mirkin CA, Stegh AH.

Sci Transl Med. 2013 Oct 30;5(209):209ra152. doi: 10.1126/scitranslmed.3006839.

3.

Biomimetic, synthetic HDL nanostructures for lymphoma.

Yang S, Damiano MG, Zhang H, Tripathy S, Luthi AJ, Rink JS, Ugolkov AV, Singh AT, Dave SS, Gordon LI, Thaxton CS.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2511-6. doi: 10.1073/pnas.1213657110. Epub 2013 Jan 23.

4.

Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux.

Luthi AJ, Zhang H, Kim D, Giljohann DA, Mirkin CA, Thaxton CS.

ACS Nano. 2012 Jan 24;6(1):276-85. doi: 10.1021/nn2035457. Epub 2011 Dec 1.

5.

Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

McMahon KM, Mutharasan RK, Tripathy S, Veliceasa D, Bobeica M, Shumaker DK, Luthi AJ, Helfand BT, Ardehali H, Mirkin CA, Volpert O, Thaxton CS.

Nano Lett. 2011 Mar 9;11(3):1208-14. doi: 10.1021/nl1041947. Epub 2011 Feb 14.

6.

Nanotechnology for synthetic high-density lipoproteins.

Luthi AJ, Patel PC, Ko CH, Mutharasan RK, Mirkin CA, Thaxton CS.

Trends Mol Med. 2010 Dec;16(12):553-60. doi: 10.1016/j.molmed.2010.10.006. Epub 2010 Nov 17.

Supplemental Content

Loading ...
Support Center